TIDMVLG

RNS Number : 3757N

Venture Life Group PLC

19 May 2020

19 May 2020

Venture Life Group plc

("Venture Life" the "Company" or the "Group")

Director/PDMR Shareholding

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that, Chief Executive Officer , Jerry Randall and his wife, Anne Randall, each transferred 20,400 ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares") into their respective ISA accounts. These transfers were facilitated by way of a sale and repurchase at a price of 65.65 pence per Ordinary Share on 18 May 2020.

Following these transactions Jerry Randall's beneficial interest remains unchanged at 3,769,729 Ordinary Shares, representing approximately 4.5 per cent. of the Company's issued share capital.

For further information, please contact:

 
 Venture Life Group PLC                               +44(0) 1344 578004 
 Jerry Randall, Chief Executive Officer 
 
 Cenkos Securities plc (Nomad and Broker)             +44(0)20 7397 8900 
 Mark Connelly / Stephen Keys / Cameron MacRitchie 
  (Corporate Finance) 
 Russell Kerr / Michael Johnson (Sales) 
 
 
  Alma PR                                             +44(0)20 3405 0208 
 Rebecca Sanders-Hewett / Hilary Buchanan / 
  Helena Bogle / Jessica Joynson 
 
 
 

About Venture Life ( www.venture-life.com )

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 
  1   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Jerry Randall 
     ------------------------  -------------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status           Chief Executive Officer 
     ------------------------  -------------------------------------- 
 b)   Initial notification      Initial Notification 
       /Amendment 
     ------------------------  -------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                      Venture Life Group plc 
     ------------------------  -------------------------------------- 
 b)   LEI                       213800S8CZUPLAB2KC70 
     ------------------------  -------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of            Ordinary Shares of 0.3p each in 
       the financial             Venture Life Group plc 
       instrument, type 
       of instrument 
     ------------------------  -------------------------------------- 
 b)   Identification            GB00BFPM8908 
       code 
     ------------------------  -------------------------------------- 
 c)   Nature of the             Sale and repurchase of shares through 
       transaction               ISA 
     ------------------------  -------------------------------------- 
 d)   Price and volumes          Share Sale      Share Purchase 
                                  20,400 shares   20,400 shares 
                                                 --------------- 
                                  65.50 pence     65.65 pence 
                                                 --------------- 
                                  GBP13,361.00    GBP13,393.60 
                                                 --------------- 
     ------------------------  -------------------------------------- 
 e)   Aggregated information     See above 
       - Aggregated 
       volume 
       - Price 
     ------------------------  -------------------------------------- 
 f)   Date of the transaction   18 May 2020 
     ------------------------  -------------------------------------- 
 g)   Place of the              London Stock Exchange 
       transaction 
     ------------------------  -------------------------------------- 
 
 
  1   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Anne Randall 
     ------------------------  ----------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status           Anne Randall a person closely associated 
                                 with Jerry Randall Chief Executive 
                                 Officer 
     ------------------------  ----------------------------------------- 
 b)   Initial notification      Initial Notification 
       /Amendment 
     ------------------------  ----------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                      Venture Life Group plc 
     ------------------------  ----------------------------------------- 
 b)   LEI                       213800S8CZUPLAB2KC70 
     ------------------------  ----------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of            Ordinary Shares of 0.3p each in 
       the financial             Venture Life Group plc 
       instrument, type 
       of instrument 
     ------------------------  ----------------------------------------- 
 b)   Identification            GB00BFPM8908 
       code 
     ------------------------  ----------------------------------------- 
 c)   Nature of the             Sale and repurchase of shares through 
       transaction               ISA 
     ------------------------  ----------------------------------------- 
 d)   Price and volumes          Share Sale      Share Purchase 
                                  20,400 shares   20,400 shares 
                                                 --------------- 
                                  65.50 pence     65.65 pence 
                                                 --------------- 
                                  GBP13,361.00    GBP13,393.60 
                                                 --------------- 
     ------------------------  ----------------------------------------- 
 e)   Aggregated information     See above 
       - Aggregated 
       volume 
       - Price 
     ------------------------  ----------------------------------------- 
 f)   Date of the transaction   18 May 2020 
     ------------------------  ----------------------------------------- 
 g)   Place of the              London Stock Exchange 
       transaction 
     ------------------------  ----------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFLFFFEIIALII

(END) Dow Jones Newswires

May 19, 2020 08:29 ET (12:29 GMT)